NMDT (%)Path (%)NOS (%)CNS (%) Weston Area Health 9589.5  70.5  5.7  66.3  Yeovil District Hospital 8296.3  54.9  22.9  82.9  University Hospitals.

Slides:

Advertisements

Similar presentations

HE Advisers’ Day National Networks for Collaborative Outreach.

Advertisements

An introduction to the Peninsula Purchasing & Supply Alliance (PPSA)

Bristol Health Serviecs Plan V.1 Bristol Health Services Plan – Core Presentation – v.1.1.

S Strong 1,2, NS Blencowe 1,2,T Fox 1, C Reid 3, T Crosby 4, H.Ford 5, J M Blazeby 1,2 1 School of Social and Community Medicine, Canynge Hall, University.

Cancer Summit Plymouth Hospitals NHS Trust 12 th February 2015 Ruth Bridgeman - Programme Director, National Peer Review Programme.

BSc Healthcare Sciences. The biological basis of medicine Shapes the modern agenda. Studying healthcare science enables you to understand the scientific.

NATIONAL CANCER PATIENT EXPERIENCE SURVEY REQUEST FROM LEAD CANCER NURSES: TO PUT THE NATIONAL CANCER PATIENT EXPERIENCE SURVEY RESULTS AND ACTIONS ON.

SW Clinical Senate Emergency Surgical Data. SW wide data.

Peninsula Purchasing and Supply Alliance An introduction to the Peninsula Purchasing & Supply Alliance (PPSA)

Secondary care nursing provision in Somerset. Andre Clinchant, Lead Nurse, Taunton & Somerset NHS trust.

National Cancer Survivorship Initiative - Models of Care The South West Regional CYP Oncology Shared Care Network.

Devon & Severn Inshore Fisheries & Conservation Authority District Tim Robbins Chief Officer.

STAFF SURVEY MAY CONTEXT Survey undertaken between September and December 2011 National response rate was 54% Survey consists of 38 questions based.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

ENT, OMF and Head and Neck Cancer Services Review Mary Hutton 27 th January 2011.

The Spatial Strategy sub regional emphases. 1What is / isn’t RSS? 2How did we get to where we are with RSS? 3Myths about RSS 4Realism….about growth and.

The Good, The Bad and The Patient Choice! Colorectal Patient Pathways Across the Network Presented by: Teresa Coombes Cancer, Oncology, Haematology and.

Haematology Dr Victoria Hervey Chair Haematology NSSG North of England Cancer Network Annual Conference 20 September 2013.

Delivering clinical research to make patients, and the NHS, better Gynaecology SSG Sept 2015 Research Jenny Forrest, Sub Specialty Lead Wendy Cook, Research.

Delivering clinical research to make patients, and the NHS, better Colorectal SSG March 2015 Research Wendy Cook, Research Delivery Manager dd/mm/yyyy.

Delivering clinical research to make patients, and the NHS, better Upper GI SSG March 2015 Research Wendy Cook, Research Delivery Manager dd/mm/yyyy.

Teaching Schools in the South West JENNY BLUNDEN.

Delivering clinical research to make patients, and the NHS, better Urology SSG 22nd April 2015 Research Wendy Cook, Research Delivery Manager Dr Mohini.

Improving Outcomes in Lung Cancer Project - ILCOP Jeanette Draffan Macmillan Lung CNS NCLFN representative ILCOP.

Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service

Teenage conceptions: progress Anglia and Essex 2Teenage conceptions: progress Percentage change in under 18 conception rate

TRIAL PARTICIPATION IN THE OVER 60s: A RE-AUDIT OF THE MANAGEMENT OF AML IN THE SOUTH WEST OF ENGLAND South West Cancer Intelligence Service

Delivering clinical research to make patients, and the NHS, better Skin SSG – Research 18 th June 2015 Dr Toby Talbot, Consultant Oncologist Wendy Cook,

Delivering clinical research to make patients, and the NHS, better Head & Neck SSG Research – 2015/16 30/04/2015 David Hwang Consultant Oncologist Wendy.

South West Public Health Observatory Paul Brown Acting Director.

Charlie Comins 10/11/15. Bristol Experience Treated first patient in Feb 2014 Aim to treat 12 patients in first year Treated 25 patients in first 12 months.

Is it really possible to improve quality and reduce cost in the NHS? Dr Steven Allder

SABR Update Breast SSG June 2017.

Network Audit on Virology Testing prior to R-Chemotherapy in patients with newly diagnosed DLBCL January to June 2016 Presented by Karan Wadhera.

Supplementary Figure 1. Importance of first neighbours in breast cancer, hepatocellular carcinoma and non-small cell lung cancer in the SignaLink network.

HANA Audit Update for SSG

Breast Cancer Research Report SWAG Site Specific Group

Local Directgov Update South West esd toolkit 26/1/2011

SWAG Cancer Alliance Update

Cancer 62 day rapid recovery plan South region

National Lung Cancer Audit

The UHBristol experience of implementing the ‘recovery package’

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

Enhancing Patient Care in Advanced NSCLC Through Clinician-Patient Partnership.

SWAG Cancer Alliance Update

Skin Tumour Group National Perspective

Breast SSG 11th March 2015 Research Wendy Cook, Research Delivery Manager dd/mm/yyyy.

Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance

Results from the first National Lung Cancer Organisational Audit.

Haematology SSG 7th November 2018

National Cancer Patient Experience (NCPES) Results 2017

SW Alliances’ Rapid Diagnostic Pathway for Lung Cancer

SWAG Cancer Alliance Update

National Cancer Patient Experience (NCPES) Results 2017

National Cancer Patient Experience Survey

Private Sector Chairperson independent employers)

2016 NCPES Inpatient and day case adult cancer patients, discharged from hospital 01/04/16 – 30/06/16 Sent postal questionnaires Oct’16 – March ’17 National.

Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance

Upper GI SSG Meeting Statistics

National Cancer Patient Experience (NCPES) Results 2017

SWAG SSG Lung Cancer Meeting

Sian Middleton, Lead Nurse for Cancer, Gloucestershire Hospitals.

SWAG Cancer Network Meeting 23 May 2018

Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey Daniel Morgensztern, MD, Shean Huey Ng,

Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.

National Oesophago-Gastric Cancer Audit

Surgical resection update

Shaping the BNSSG Primary Care Strategy Workshop

Comparison of primary end-points against guidelines

Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. Relative frequencies of FGFR aberrations in non–small cell lung carcinoma. A,

Presentation transcript:

NMDT (%)Path (%)NOS (%)CNS (%) Weston Area Health  70.5  5.7  66.3  Yeovil District Hospital  54.9  22.9  82.9  University Hospitals Bristol  65.5  17.9  95.3  South Devon Healthcare  62.9  0.0  75.8  Taunton and Somerset  62.6  5.9  82.8  Northern Devon Healthcare  56.7  23.0  89.8  Royal United Hospital Bath  47.8  5.8  87.9  Royal Cornwall Hospitals  82.8  5.4  94.8  Royal Devon and Exeter  77.5  2.2  98.0  Plymouth Hospitals  54.8  20.3  79.0  Gloucestershire Hospitals  84.8  5.5  84.1  North Bristol  66.4  12.0  58.5  Whole Network 2,  66.7  9.1  82.8  MDT: multidisciplinary team; Path: pathological confirmation rate NOS: nonsmall cell cancer not otherwise specified; CNS: patients seen by lung nurse specialist

Treatment percentages All treatmentNSCLC surgeryNSCLC chemoSCLC chemo Weston Area Health 64.2  22.0  82.4  72.7  Yeovil District Hospital 57.3  17.8  75.0  85.7  University Hospitals Bristol 64.9  13.2  74.4  81.3  South Devon Healthcare 61.8  11.5  59.5  72.2  Taunton and Somerset 68.2  20.5  78.7  81.8  Northern Devon Healthcare 55.9  12.1  61.9  80.0  Royal United Hospital Bath 63.4  18.7  51.0  75.0  Royal Cornwall Hospitals 82.3  13.8  71.8  81.0  Royal Devon and Exeter 73.5  17.3  57.4  82.4  Plymouth Hospitals 57.4  17.5  58.7  56.7  Gloucestershire Hospitals 65.9  18.6  48.5  61.1  North Bristol 51.0  22.6  52.9  68.8  Whole Network 64.1  17.4  61.0  73.0  NSCLC: non small cell lung cancer; SCLC: small cell lung cancer

ODD RATIOs of treatments All treatmentNSCLC surgeryNSCLC chemoSCLC chemo Weston Area Health 1.37  1.68  3.11  1.17  Yeovil District Hospital 1.09  0.91  3.52  3.23  University Hospitals Bristol 1.39  0.98  2.22  2.19  South Devon Healthcare 1.25  0.66  1.26  1.28  Taunton and Somerset 1.77  2.17  3.49  1.97  Northern Devon Healthcare 0.95  0.67  1.20  2.48  Royal United Hospital Bath 0.97  1.07  0.86  0.89  Royal Cornwall Hospitals 5.94  1.01  1.48  2.96  Royal Devon and Exeter 2.22  1.16  1.4  2.17  Plymouth Hospitals 0.92  0.99  1.1  0.53  Gloucestershire Hospitals 1.28  1.34  0.7  0.58  North Bristol 0.65  1.75  0.9  1.08  Whole Network 1.32  1.17  1.27  1.27  NSCLC: non small cell lung cancer; SCLC: small cell lung cancer